PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
Turnover
16.67%
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$93.2M
AUM Growth
+$3.31M
(+3.7%)
Cap. Flow
+$475K
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
34.84%
Holding
132
New
12
Increased
21
Reduced
60
Closed
11
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NSPH
NANOSPHERE INC. COM NEW
NSPH
|
+$2.12M |
| 2 |
Xtant Medical Holdings
XTNT
|
+$1.24M |
| 3 |
Cerenome
CNSY
|
+$938K |
| 4 |
VYNT
Vyant Bio, Inc. Common Stock
VYNT
|
+$891K |
| 5 |
AEGN
Aegion Corp
AEGN
|
+$850K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Optoelectronics
AAOI
|
+$1.03M |
| 2 |
Synchrony
SYF
|
+$822K |
| 3 |
NeoGenomics
NEO
|
+$656K |
| 4 |
SQNM
SEQUENOM INC NEW
SQNM
|
+$516K |
| 5 |
Apple
AAPL
|
+$457K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.76% |
| 2 | Industrials | 11.04% |
| 3 | Technology | 10.93% |
| 4 | Consumer Staples | 5.64% |
| 5 | Consumer Discretionary | 3.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
STJ
1
DELISTED
St Jude Medical
STJ
| $5.57M | 5.98% |
90,188
-5,150
| -5% | -$325K |
2013 Q2
10 quarters
|
|
|
2
NeoGenomics
NEO
$2.18B
| $5.54M | 5.95% |
704,432
-89,580
| -11% | -$656K |
2013 Q2
10 quarters
|
|
3
Rockwell Medical
RMTI
$31.6M
| $4.99M | 5.35% |
4,428
-9
| -0.2% | -$10.5K |
2013 Q2
10 quarters
|
|
4
Axogen
AXGN
$2.08B
| $3.22M | 3.45% |
643,758
-18,942
| -3% | -$93.6K |
2013 Q3
9 quarters
|
|
5
LeMaitre Vascular
LMAT
$1.88B
| $2.52M | 2.71% |
146,202
-22,493
| -13% | -$325K |
2013 Q2
10 quarters
|
|
|
CSII
6
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.33M | 2.5% |
154,050
+8,200
| +6% | +$122K |
2013 Q2
10 quarters
|
|
7
Altimmune
ALT
$457M
| $2.27M | 2.44% |
3,982
-70
| -2% | -$34.9K |
2013 Q2
10 quarters
|
|
8
ePlus
PLUS
$2.45B
| $2.15M | 2.3% |
92,000
-2,000
| -2% | -$44.9K |
2013 Q2
10 quarters
|
|
9
Pfizer
PFE
$167B
| $1.99M | 2.14% |
65,010
-2,108
| -3% | -$66.3K |
2013 Q2
10 quarters
|
|
10
AtriCure
ATRC
$2.91B
| $1.89M | 2.03% |
84,250
+250
| +0.3% | +$5.15K |
2013 Q2
10 quarters
|
|
11
DELISTED
Assertio
ASRT
| $1.8M | 1.93% |
1,653
+4
| +0.2% | +$4.5K |
2013 Q3
9 quarters
|
|
|
SVU
12
DELISTED
SUPERVALU Inc.
SVU
| $1.75M | 1.88% |
36,879
-250
| -0.7% | -$11.9K |
2013 Q2
10 quarters
|
|
13
Eli Lilly
LLY
$1.08T
| $1.71M | 1.83% |
20,300
| – | – |
2013 Q2
10 quarters
|
|
14
Deluxe
DLX
$1.03B
| $1.69M | 1.81% |
30,908
-300
| -1% | -$17.3K |
2013 Q2
10 quarters
|
|
|
ZIXI
15
DELISTED
Zix Corporation
ZIXI
| $1.58M | 1.7% |
311,839
-2,450
| -0.8% | -$12.6K |
2013 Q2
10 quarters
|
|
16
UnitedHealth
UNH
$352B
| $1.57M | 1.68% |
13,350
| – | – |
2013 Q2
10 quarters
|
|
17
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.47M | 1.58% |
1,139,854
-104,743
| -8% | -$143K |
2015 Q2
2 quarters
|
|
18
DELISTED
BioTelemetry, Inc.
BEAT
| $1.39M | 1.49% |
119,050
+25,600
| +27% | +$324K |
2015 Q3
1 quarter
|
|
|
MEET
19
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $1.38M | 1.48% |
385,225
-86,875
| -18% | -$228K |
2014 Q3
5 quarters
|
|
20
Global Payments
GPN
$21.1B
| $1.26M | 1.36% |
19,600
+200
| +1% | +$13.5K |
2014 Q1
7 quarters
|
|
21
Ionis Pharmaceuticals
IONS
$7.14B
| $1.23M | 1.32% |
19,900
-450
| -2% | -$24.3K |
2013 Q2
10 quarters
|
|
22
SPS Commerce
SPSC
$3.06B
| $1.2M | 1.28% |
34,100
-1,200
| -3% | -$43.8K |
2015 Q2
2 quarters
|
|
23
CVS Health
CVS
$115B
| $1.19M | 1.28% |
12,183
-2,000
| -14% | -$196K |
2013 Q2
10 quarters
|
|
|
24
Xtant Medical Holdings
XTNT
$44.6M
| $1.18M | 1.27% |
+35,233
| New | +$1.24M |
2015 Q4
0 quarters
|
|
|
HDS
25
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.18M | 1.26% |
39,200
-950
| -2% | -$28.5K |
2014 Q4
4 quarters
|
|
Similar funds
AA
WA
AC
BCVI
HAP
RHIG
CWM
SI
Perkins Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Perkins Capital Management held 132 positions worth $93.2M, up 3.7% from $89.9M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Perkins Capital Management's Q4 2015 filing shows 12 new, 21 increased, 60 reduced and 11 closed positions. Its largest new stake was NANOSPHERE INC. COM NEW: 1,540,594 shares worth $943K. The largest sale was Applied Optoelectronics, an estimated $1.03M.
By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 56% a quarter earlier, followed by Industrials and Technology.
- Perkins Capital Management's largest Q4 2015 buy was NANOSPHERE INC. COM NEW: 1,540,594 shares worth $943K.
- Perkins Capital Management added most to EnteroMedics Inc. in Q4 2015, an estimated $355K increase.
- Perkins Capital Management's biggest Q4 2015 reduction was NeoGenomics, cutting an estimated $656K.
- Perkins Capital Management fully exited Applied Optoelectronics in Q4 2015, selling an estimated $1.03M.
- Perkins Capital Management's ten largest holdings make up 35% of its $93.2M portfolio in Q4 2015.
- Perkins Capital Management opened 12 new positions and closed 11 in Q4 2015.
- Perkins Capital Management's portfolio value rose 3.7% quarter-over-quarter to $93.2M.
Based on Perkins Capital Management's 13F filing for Q4 2015, filed 28 Jan 2016.